tetano
Editor, Senior Moderator
Cureus
. 2022 Aug 12;14(8):e27953.
doi: 10.7759/cureus.27953. eCollection 2022 Aug.
Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
Hani Abdalla[SUP] 1 [/SUP], Ebrahim Ebrahim[SUP] 2 [/SUP]
Affiliations
Abstract
Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine.
Keywords: alopecia areata; alopecia areata universalis; covid-19; hair loss; sars-cov2; vaccine safety.
. 2022 Aug 12;14(8):e27953.
doi: 10.7759/cureus.27953. eCollection 2022 Aug.
Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
Hani Abdalla[SUP] 1 [/SUP], Ebrahim Ebrahim[SUP] 2 [/SUP]
Affiliations
- PMID: 35975094
- PMCID: PMC9375056
- DOI: 10.7759/cureus.27953
Abstract
Alopecia areata (AA) is a patchy autoimmune nonscarring hair loss. Various pathophysiological explanations are described with immune dysregulation being the most well established. In this report, we describe a 63-year-old lady with AA recurrence, in the form of AA universalis, after 32 years of remission, following administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. We also briefly reviewed published cases with similar presentations after receiving the SARS-CoV-2 vaccine.
Keywords: alopecia areata; alopecia areata universalis; covid-19; hair loss; sars-cov2; vaccine safety.